The "Gold Sodium Thiosulfate (CAS 10233-88-2) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.This ...

Equities research analysts at Wedbush upped their Q1 2025 earnings estimates for shares of Fennec Pharmaceuticals in a ...

Fennec Pharmaceuticals shares were down after the company reported fourth-quarter results. The stock was recently down 10% to $6.20 and is down about 2% this year.

Norgine Pharmaceuticals Ltd., has launched PEDMARQSI (sodium thiosulfate injection) in Germany. This marks a significant advancement in the global commercialization of the first approved therapy ...

[21] In our experience, patch-test results were negative at day = but became positive by day 7 or later for the following metals: gold sodium thiosulfate 0.5%, palladium chloride 2%, potassium ...

Fennec Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development of sodium thiosulfate for the prevention of ototoxicity from cisplatin in pediatric cancer patients.

This requires a conical flask and gas syringe. Sodium thiosulfate reacts with dilute hydrochloric acid to produce sodium chloride, water, sulfur dioxide and sulfur. The sulfur makes the solution ...